Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Triple Synergistic Modulation via Sn Doping in Tetrahedrites: Electronic Structure, DOS, and Scattering Engineering for a High Thermoelectric Performance.

ACS applied materials & interfaces·2025

Same author

Effect of 1-DNJ on Oxidative Stress-Induced Apoptosis in Porcine Ovarian GCs Through Modulation of the PERK-ATF4/MFN2 Signaling Pathway.

Antioxidants (Basel, Switzerland)·2025

Same author

Large-sized aerobic granular biofilm: stable biotechnology to improve nitrogen removal and reduce sludge yield.

Bioresource technology·2025

Same author

Effects of acceptance and commitment therapy plus exercise for older adults with chronic low back pain: A preliminary cluster randomized controlled trial with qualitative interviews.

The journal of pain·2025

Same author

Precisely tuning the electronic states of organic polymer electrocatalysts via thiophene-based moieties for enhanced oxygen reduction reaction.

iScience·2025

Same author

Design of self-assembled micelles based on natural dual-targeting strategies and evaluation of their anti-liver cancer effects as drug delivery systems.

NPJ precision oncology·2025

Search research articles

Related Experiment Video

Updated: Jun 24, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Decoupling the correlation between cytotoxic and exhausted T lymphocyte states enhances melanoma immunotherapy

Binbin Wang¹, Kun Wang¹, Di Wu²

¹Cancer Data Science Laboratory, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD USA.

|June 4, 2024

Summary

Cytotoxic T lymphocyte (CTL) and exhausted T lymphocyte (ETL) signatures predict immune checkpoint inhibitor (ICI) response. A new method, DETACH, improves prediction accuracy by identifying patient subsets with low CTL and ETL correlation.

Keywords:

Biocomputational method Biological sciences Cancer Computational bioinformatics Immunology

More Related Videos

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Related Experiment Videos

Last Updated: Jun 24, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Area of Science:

Immunology
Computational Biology
Oncology

Background:

Cytotoxic T lymphocyte (CTL) and terminal exhausted T lymphocyte (ETL) activities are critical for immune checkpoint inhibitor (ICI) response.
Current transcriptomic signatures of ETL and CTL have limited efficacy in predicting ICI response.

Purpose of the Study:

To investigate the correlation between ETL and CTL expression signatures across various cancers.
To develop a computational method (DETACH) to improve the prediction of ICI response by addressing the interplay between CTL and ETL signatures.
To identify a gene set that enhances CTL prediction accuracy in specific patient subsets.

Main Methods:

Analysis of transcriptomic data from TCGA and single-cell cohorts.
Development of the DETACH computational method to identify gene sets with low CTL and ETL correlation.
Validation of DETACH's predictive performance against existing signatures.

Main Results:

A strong positive correlation between ETL and CTL expression signatures was observed in most cancers.
DETACH successfully identified a subset of melanoma patients with low CTL and ETL correlation.
DETACH significantly enhanced CTL prediction accuracy for ICI response, outperforming existing methods.
DETACH signature gene activity correlated positively with lymphocyte infiltration and reactive T cells in the tumor microenvironment (TME).

Conclusions:

The mutual canceling effects of CTL and ETL signatures may limit their individual predictability for ICI response.
DETACH offers an improved approach for predicting ICI response by focusing on specific patient subsets.
DETACH advances the understanding of CTL cell states within the TME and their association with treatment outcomes.